Cargando…
The Sinai Robotic Surgery Trial in HPV-related oropharyngeal squamous cell carcinoma (SIRS 2.0 trial) – study protocol for a phase II non-randomized non-inferiority trial
BACKGROUND: Human papillomavirus associated oropharyngeal squamous cell carcinoma (HPVOPSCC) usually affects a younger patient population. As such, the risk for long term toxicity associated with therapy is an important consideration. Multiple trials focused on de-escalation of therapy to preserve s...
Autores principales: | Chai, Raymond L., Ferrandino, Rocco M., Barron, Christine, Donboli, Kianoush, Roof, Scott A., Khan, Mohemmed N., Teng, Marita S., Posner, Marshall R., Bakst, Richard L., Genden, Eric M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453550/ https://www.ncbi.nlm.nih.gov/pubmed/36091121 http://dx.doi.org/10.3389/fonc.2022.965578 |
Ejemplares similares
-
Adjuvant Radiation Therapy Alone for HPV Related Oropharyngeal Cancers with High Risk Features
por: Su, William, et al.
Publicado: (2016) -
Quality of Life Analysis of HPV-Positive Oropharyngeal Cancer Patients in a Randomized Trial of Reduced-Dose Versus Standard Chemoradiotherapy: 5-Year Follow-Up
por: Takahashi, Mai, et al.
Publicado: (2022) -
The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer
por: Dave, Eesha, et al.
Publicado: (2017) -
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
por: Hanna, Glenn J., et al.
Publicado: (2023) -
Immunotherapy in HPV-Related Oropharyngeal Cancers
por: Roof, Logan, et al.
Publicado: (2023)